Literature DB >> 12062668

Development and validation of a liquid chromatography/tandem mass spectrometry (LC/MS/MS) method for the determination of ribavirin in human plasma and serum.

Wilson Z Shou1, Hai Zhi Bu, Thomas Addison, Xiangyu Jiang, Weng Naidong.   

Abstract

A liquid chromatography/tandem mass spectrometry (LC/MS/MS) method was developed for the analysis of antiviral agent ribavirin in human plasma and serum. The samples (0.1 ml) were extracted from the matrix using a simple protein precipitation procedure. The supernatants were evaporated to dryness, reconstituted and injected onto the LC/MS/MS system. The chromatography separation was achieved on a silica column operated with an aqueous-organic mobile phase. The use of a silica column not only provided adequate retention for the extremely polar compound of ribavirin, but also enhanced electrospray ionization sensitivity with the use of high percentage organic solvent in the mobile phase. The method has been validated over the concentration range of 10-10000 ng/ml ribavirin in human plasma and serum. Bamethan was used as the internal standard. The protein precipitation extraction has been automated based on 96-well format with the use of robotic liquid handlers to improve the overall throughput of the analysis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12062668     DOI: 10.1016/s0731-7085(02)00003-1

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  3 in total

1.  HPLC-MS/MS method for the intracellular determination of ribavirin monophosphate and ribavirin triphosphate in CEM ss cells.

Authors:  Margarita Meléndez; Osvaldo Rosario; Beatriz Zayas; José F Rodríguez
Journal:  J Pharm Biomed Anal       Date:  2009-02-13       Impact factor: 3.935

2.  Feasibility of ribavirin therapeutic drug monitoring in hepatitis C.

Authors:  Francois-Ludovic Sauvage; Francoise Stanke-Labesque; Marie-Claude Gagnieu; Jean-Francois Jourdil; Gerard Babany; Pierre Marquet
Journal:  Ther Drug Monit       Date:  2009-06       Impact factor: 3.681

3.  Kinetic determination of ribavirin in drug formulations.

Authors:  A M El-Brashy; Z A Sheribah; M K Sharaf El-Din; R M El-Gamal
Journal:  Int J Biomed Sci       Date:  2007-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.